Form 8-K - Current report:
SEC Accession No. 0001564590-22-001402
Filing Date
2022-01-18
Accepted
2022-01-18 07:00:30
Documents
12
Period of Report
2022-01-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K MISC - UT ANNOUNCEMENT mnkd-8k_20220118.htm   iXBRL 8-K 29049
  Complete submission text file 0001564590-22-001402.txt   153008

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20220118.xsd EX-101.SCH 5709
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20220118_lab.xml EX-101.LAB 18663
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20220118_pre.xml EX-101.PRE 11139
6 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-8k_20220118_htm.xml XML 3410
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 22533597
SIC: 2834 Pharmaceutical Preparations